ES2285211T3 - Sondas de acido nucleico y cebadores de amplio intervalo de regiones en los genes de la topoisomerasa, y metodos en los que se usan. - Google Patents
Sondas de acido nucleico y cebadores de amplio intervalo de regiones en los genes de la topoisomerasa, y metodos en los que se usan. Download PDFInfo
- Publication number
- ES2285211T3 ES2285211T3 ES03775414T ES03775414T ES2285211T3 ES 2285211 T3 ES2285211 T3 ES 2285211T3 ES 03775414 T ES03775414 T ES 03775414T ES 03775414 T ES03775414 T ES 03775414T ES 2285211 T3 ES2285211 T3 ES 2285211T3
- Authority
- ES
- Spain
- Prior art keywords
- baselineskip
- sequences
- dna
- bacterial species
- dddseqskip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 101710183280 Topoisomerase Proteins 0.000 title claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 title claims description 41
- 108020004711 Nucleic Acid Probes Proteins 0.000 title abstract description 10
- 239000002853 nucleic acid probe Substances 0.000 title abstract description 10
- 238000000034 method Methods 0.000 title description 77
- 230000001580 bacterial effect Effects 0.000 claims abstract description 119
- 241000894007 species Species 0.000 claims abstract description 103
- 241000894006 Bacteria Species 0.000 claims abstract description 48
- 208000015181 infectious disease Diseases 0.000 claims abstract description 34
- 238000003745 diagnosis Methods 0.000 claims abstract description 26
- 238000002405 diagnostic procedure Methods 0.000 claims abstract description 16
- 238000003752 polymerase chain reaction Methods 0.000 claims description 72
- 239000000523 sample Substances 0.000 claims description 69
- 101150013736 gyrB gene Proteins 0.000 claims description 46
- 101150012629 parE gene Proteins 0.000 claims description 43
- 239000000203 mixture Substances 0.000 claims description 40
- 238000009396 hybridization Methods 0.000 claims description 38
- 108091034117 Oligonucleotide Proteins 0.000 claims description 35
- 108020005187 Oligonucleotide Probes Proteins 0.000 claims description 34
- 239000002751 oligonucleotide probe Substances 0.000 claims description 34
- 108010041052 DNA Topoisomerase IV Proteins 0.000 claims description 29
- 230000003321 amplification Effects 0.000 claims description 27
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 27
- 241000193998 Streptococcus pneumoniae Species 0.000 claims description 19
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 18
- 229940031000 streptococcus pneumoniae Drugs 0.000 claims description 18
- 241000191967 Staphylococcus aureus Species 0.000 claims description 17
- 206010057190 Respiratory tract infections Diseases 0.000 claims description 16
- 230000000295 complement effect Effects 0.000 claims description 16
- 125000003729 nucleotide group Chemical group 0.000 claims description 16
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims description 16
- 239000007787 solid Substances 0.000 claims description 16
- 239000002773 nucleotide Substances 0.000 claims description 15
- 241000588655 Moraxella catarrhalis Species 0.000 claims description 14
- 241000193996 Streptococcus pyogenes Species 0.000 claims description 14
- 239000011521 glass Substances 0.000 claims description 14
- 241001647372 Chlamydia pneumoniae Species 0.000 claims description 12
- 241000606768 Haemophilus influenzae Species 0.000 claims description 11
- 241000589242 Legionella pneumophila Species 0.000 claims description 11
- 229940047650 haemophilus influenzae Drugs 0.000 claims description 11
- 229940115932 legionella pneumophila Drugs 0.000 claims description 11
- 241000605952 Fusobacterium necrophorum Species 0.000 claims description 10
- 241000202934 Mycoplasma pneumoniae Species 0.000 claims description 10
- 238000001514 detection method Methods 0.000 claims description 9
- 239000013641 positive control Substances 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 9
- 238000005406 washing Methods 0.000 claims description 9
- 241000588724 Escherichia coli Species 0.000 claims description 8
- 108020001019 DNA Primers Proteins 0.000 claims description 7
- 239000003155 DNA primer Substances 0.000 claims description 7
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 claims description 6
- 241000588652 Neisseria gonorrhoeae Species 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 230000000241 respiratory effect Effects 0.000 claims description 5
- 238000009007 Diagnostic Kit Methods 0.000 claims description 4
- 238000005516 engineering process Methods 0.000 claims description 2
- 108091036078 conserved sequence Proteins 0.000 abstract description 13
- 208000035143 Bacterial infection Diseases 0.000 abstract description 6
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 6
- 108020004414 DNA Proteins 0.000 description 128
- 239000013615 primer Substances 0.000 description 89
- 238000010367 cloning Methods 0.000 description 19
- 239000012634 fragment Substances 0.000 description 17
- 238000013461 design Methods 0.000 description 15
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000012163 sequencing technique Methods 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 9
- 244000052769 pathogen Species 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- 230000035945 sensitivity Effects 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 239000000872 buffer Substances 0.000 description 7
- 150000007523 nucleic acids Chemical class 0.000 description 7
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- 108020000946 Bacterial DNA Proteins 0.000 description 6
- 241000282326 Felis catus Species 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 206010035664 Pneumonia Diseases 0.000 description 6
- 241001134658 Streptococcus mitis Species 0.000 description 6
- 241000194025 Streptococcus oralis Species 0.000 description 6
- 125000003275 alpha amino acid group Chemical group 0.000 description 6
- 239000013610 patient sample Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 239000003550 marker Substances 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- 230000004544 DNA amplification Effects 0.000 description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
- 229940127266 GyrB and ParE Drugs 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 4
- 108010006785 Taq Polymerase Proteins 0.000 description 4
- 238000007821 culture assay Methods 0.000 description 4
- 230000002068 genetic effect Effects 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 241000606766 Haemophilus parainfluenzae Species 0.000 description 3
- 208000005141 Otitis Diseases 0.000 description 3
- 206010033078 Otitis media Diseases 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 3
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 3
- 238000004925 denaturation Methods 0.000 description 3
- 230000036425 denaturation Effects 0.000 description 3
- 231100000676 disease causative agent Toxicity 0.000 description 3
- 208000019258 ear infection Diseases 0.000 description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 3
- 229960005542 ethidium bromide Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000002987 primer (paints) Substances 0.000 description 3
- 108020004418 ribosomal RNA Proteins 0.000 description 3
- FZHAPNGMFPVSLP-UHFFFAOYSA-N silanamine Chemical compound [SiH3]N FZHAPNGMFPVSLP-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 206010044008 tonsillitis Diseases 0.000 description 3
- 108091035707 Consensus sequence Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 241001505901 Streptococcus sp. 'group A' Species 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000011203 antimicrobial therapy Methods 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 206010001076 Acute sinusitis Diseases 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 241000186033 Alloiococcus Species 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241001445332 Coxiella <snail> Species 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 230000003682 DNA packaging effect Effects 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 208000032163 Emerging Communicable disease Diseases 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 102100036250 GPI mannosyltransferase 4 Human genes 0.000 description 1
- 206010018364 Glomerulonephritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101001074618 Homo sapiens GPI mannosyltransferase 4 Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 241000589248 Legionella Species 0.000 description 1
- 208000007764 Legionnaires' Disease Diseases 0.000 description 1
- 241000588621 Moraxella Species 0.000 description 1
- 241001478292 Moraxella caviae Species 0.000 description 1
- 241001478293 Moraxella cuniculi Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 241000204048 Mycoplasma hominis Species 0.000 description 1
- 241000588653 Neisseria Species 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 208000037065 Subacute sclerosing leukoencephalitis Diseases 0.000 description 1
- 206010042297 Subacute sclerosing panencephalitis Diseases 0.000 description 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 1
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 201000008837 acute maxillary sinusitis Diseases 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000007846 asymmetric PCR Methods 0.000 description 1
- 238000000376 autoradiography Methods 0.000 description 1
- 230000027455 binding Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- YTRQFSDWAXHJCC-UHFFFAOYSA-N chloroform;phenol Chemical compound ClC(Cl)Cl.OC1=CC=CC=C1 YTRQFSDWAXHJCC-UHFFFAOYSA-N 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 230000037029 cross reaction Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 210000000959 ear middle Anatomy 0.000 description 1
- 238000002635 electroconvulsive therapy Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 238000004362 fungal culture Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 238000009533 lab test Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000008836 maxillary sinusitis Diseases 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000003239 susceptibility assay Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI20022064A FI113549B (fi) | 2002-11-19 | 2002-11-19 | Diagnostinen menetelmä hengitystieinfektioita aiheuttavien bakteerien osoittamiseksi ja tunnistamiseksi ja menetelmässä käyttökelpoinen alukeseos |
| FI20022064 | 2002-11-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2285211T3 true ES2285211T3 (es) | 2007-11-16 |
Family
ID=8564969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES03775414T Expired - Lifetime ES2285211T3 (es) | 2002-11-19 | 2003-11-19 | Sondas de acido nucleico y cebadores de amplio intervalo de regiones en los genes de la topoisomerasa, y metodos en los que se usan. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060024675A1 (enExample) |
| EP (1) | EP1565573B1 (enExample) |
| JP (1) | JP2006509500A (enExample) |
| CN (1) | CN100572556C (enExample) |
| AT (1) | ATE357539T1 (enExample) |
| AU (1) | AU2003283446A1 (enExample) |
| CA (1) | CA2506058A1 (enExample) |
| DE (1) | DE60312726T2 (enExample) |
| DK (1) | DK1565573T3 (enExample) |
| ES (1) | ES2285211T3 (enExample) |
| FI (1) | FI113549B (enExample) |
| PT (1) | PT1565573E (enExample) |
| SI (1) | SI1565573T1 (enExample) |
| WO (1) | WO2004046379A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005333163B2 (en) | 2004-11-09 | 2011-06-16 | Gen-Probe Incorporated | Compositions and methods for detecting Group A streptococci |
| AT503401B1 (de) * | 2006-04-10 | 2007-12-15 | Arc Austrian Res Centers Gmbh | Microarray zur erkennung von pathogenen |
| EP1975253A1 (en) * | 2007-03-30 | 2008-10-01 | Institut Pasteur | Method of discrimination of the species of the enterobacteriaceae family by genotyping and its applications |
| JP5403573B2 (ja) * | 2007-08-09 | 2014-01-29 | 国立大学法人山口大学 | 肺炎原因菌検出用プライマーセット |
| FI121884B (fi) * | 2008-01-17 | 2011-05-31 | Mobidiag Oy | Menetelmä metisilliiniresistenttien stafylokokkien havaitsemiseksi ja tunnistamiseksi sekä menetelmään tarkoitettu koetin ja testipakkaus |
| FI121379B (fi) * | 2008-01-17 | 2010-10-29 | Mobidiag Oy | Menetelmä yksijuosteisen DNA:n tuottamiseksi kaksivaiheisella symmetrisellä PCR:llä sekä menetelmään tarkoitettu reagenssipakkaus |
| FI121428B (fi) * | 2008-01-17 | 2010-11-15 | Mobidiag Oy | Laajakirjoisia alukkeita, testipakkaus ja menetelmä bakteerilajien havaitsemiseksi ja tunnistamiseksi |
| CN101492731B (zh) * | 2008-12-04 | 2011-05-11 | 浙江理工大学 | 一种胶质芽孢杆菌的快速pcr检测方法 |
| GB0901709D0 (en) * | 2009-02-03 | 2009-03-11 | Q Chip Ltd | Assay products, devices and method |
| JP2013528049A (ja) * | 2010-05-19 | 2013-07-08 | キアゲン ガイサーズバーグ アイエヌシー． | 核酸の配列特異的な精製及び多重分析のための方法及び組成物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5541308A (en) * | 1986-11-24 | 1996-07-30 | Gen-Probe Incorporated | Nucleic acid probes for detection and/or quantitation of non-viral organisms |
| US5645994A (en) * | 1990-07-05 | 1997-07-08 | University Of Utah Research Foundation | Method and compositions for identification of species in a sample using type II topoisomerase sequences |
| US5210015A (en) * | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| JPH09252783A (ja) * | 1996-03-26 | 1997-09-30 | Nippon Suisan Kaisha Ltd | 腸炎ビブリオ検出のためのヌクレオチドおよびそれを用いた検出法 |
| US6087104A (en) * | 1997-03-24 | 2000-07-11 | Nippon Suisan Kaisha, Ltd. | Oligonucleotides for detection of Bacillus cereus group bacteria harmful to mammals, and method of detection with the oligonucleotides |
| JP3529255B2 (ja) * | 1997-12-12 | 2004-05-24 | 株式会社海洋バイオテクノロジー研究所 | ジャイレース遺伝子を指標とした微生物の同定・検出法 |
| CA2324990A1 (en) * | 1998-04-01 | 1999-10-07 | Linda M. Weigel | Oligonucleotide probes for detecting enterobacteriaceae and quinolone-resistant enterobacteriaceae |
| JP2000060570A (ja) * | 1998-08-27 | 2000-02-29 | Canon Inc | 新規核酸断片及びこれを用いた微生物の検出方法 |
| GB9904804D0 (en) * | 1999-03-02 | 1999-04-28 | King S College London | Identification of bacteria |
| WO2000061796A1 (de) * | 1999-04-10 | 2000-10-19 | Merlin Gesellschaft Für Mikrobiologische Diagnostika Mbh | Verfahren zur genotypischen klassifizierung |
| US6346397B1 (en) * | 1999-04-12 | 2002-02-12 | Smithkline Beecham Corportion | GyrA |
| JP3565752B2 (ja) * | 1999-11-02 | 2004-09-15 | 株式会社海洋バイオテクノロジー研究所 | Ｄｎａジャイレース遺伝子中に存在する特徴的な塩基配列を用いた遅発育性マイコバクテリアの同定法及び特異的検出法 |
| WO2001036683A2 (en) * | 1999-11-16 | 2001-05-25 | Apollo Biotechnology, Inc. | Method for rapid and accurate identification of microorganisms |
| JP2001245677A (ja) * | 1999-12-27 | 2001-09-11 | Srl Inc | シゲラ属又はサルモネラ属細菌の測定用核酸及び検出方法 |
| US20020072058A1 (en) * | 2000-03-24 | 2002-06-13 | Voelker Leroy L. | Method for amplifying quinolone-resistance-determining-regions and identifying polymorphic variants thereof |
-
2002
- 2002-11-19 FI FI20022064A patent/FI113549B/fi not_active IP Right Cessation
-
2003
- 2003-11-19 AT AT03775414T patent/ATE357539T1/de active
- 2003-11-19 JP JP2004552765A patent/JP2006509500A/ja active Pending
- 2003-11-19 DE DE60312726T patent/DE60312726T2/de not_active Expired - Lifetime
- 2003-11-19 PT PT03775414T patent/PT1565573E/pt unknown
- 2003-11-19 CA CA002506058A patent/CA2506058A1/en not_active Abandoned
- 2003-11-19 DK DK03775414T patent/DK1565573T3/da active
- 2003-11-19 US US10/535,442 patent/US20060024675A1/en not_active Abandoned
- 2003-11-19 ES ES03775414T patent/ES2285211T3/es not_active Expired - Lifetime
- 2003-11-19 WO PCT/FI2003/000888 patent/WO2004046379A1/en not_active Ceased
- 2003-11-19 AU AU2003283446A patent/AU2003283446A1/en not_active Abandoned
- 2003-11-19 SI SI200330760T patent/SI1565573T1/sl unknown
- 2003-11-19 EP EP03775414A patent/EP1565573B1/en not_active Expired - Lifetime
- 2003-11-19 CN CNB2003801084108A patent/CN100572556C/zh not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1565573A1 (en) | 2005-08-24 |
| AU2003283446A1 (en) | 2004-06-15 |
| FI20022064A0 (fi) | 2002-11-19 |
| WO2004046379A9 (en) | 2004-08-26 |
| ATE357539T1 (de) | 2007-04-15 |
| CN1735694A (zh) | 2006-02-15 |
| WO2004046379A1 (en) | 2004-06-03 |
| PT1565573E (pt) | 2007-04-30 |
| SI1565573T1 (sl) | 2007-08-31 |
| EP1565573B1 (en) | 2007-03-21 |
| DE60312726D1 (de) | 2007-05-03 |
| CA2506058A1 (en) | 2004-06-03 |
| FI113549B (fi) | 2004-05-14 |
| CN100572556C (zh) | 2009-12-23 |
| DK1565573T3 (da) | 2007-07-30 |
| JP2006509500A (ja) | 2006-03-23 |
| US20060024675A1 (en) | 2006-02-02 |
| DE60312726T2 (de) | 2008-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hoshina et al. | Direct detection and amplification of Helicobacter pylori ribosomal 16S gene segments from gastric endoscopic biopsies | |
| EP2240605B1 (en) | Nucleic acid probes and broad-range primers for detecting infectious bacteria | |
| EP0452596A1 (en) | Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms | |
| ES2285211T3 (es) | Sondas de acido nucleico y cebadores de amplio intervalo de regiones en los genes de la topoisomerasa, y metodos en los que se usan. | |
| EP1375677B1 (en) | Probes for detecting and identifying helicobacter pylori | |
| KR20100061438A (ko) | 치주 질환 관련 세균의 검출 및 동정용 마이크로어레이 및 이를 이용한 세균 감염성 구강 질환 진단방법 | |
| ES2426289T3 (es) | Detección de Staphylococcus aureus e identificación de Staphylococcus aureus resistente a meticilina | |
| KR20120112001A (ko) | 구강 세균감염성질환 원인균 검출용 프라이머 및 이의 용도 | |
| ES2335987T3 (es) | Identificacion molecular de las bacterias del genero streptococcus y generos emparentados. | |
| EP2668299B1 (en) | Selective detection of haemophilus influenzae | |
| Tungpradabkul et al. | PCR-RFLP analysis of the flagellin sequences for identification ofBurkholderia pseudomalleiandBurkholderia cepaciafrom clinical isolates | |
| EP2240607A1 (en) | Method of detecting and identifying staphylococci | |
| US20070243530A1 (en) | Nucleic Acid Probes and Broad-Range Primers from Regions in Dna Directed Rna Polymerase Subunit B Genes, and Methods in Which They are Used | |
| US20020081606A1 (en) | Methods for detecting and identifying a gram positive bacteria in a sample | |
| JP4531317B2 (ja) | スピロヘータを検出するための一本鎖オリゴヌクレオチド、プローブ、プライマーおよび方法 | |
| ES2635514T3 (es) | Método para producir ADN de cadena sencilla | |
| US20070065828A1 (en) | Oligonucleotide for genotyping of mycoplasma, microarray comprising the oligonucleotide, and method for detection of species using the microarray | |
| EP1529848B1 (en) | Substances, sequences and methods for identifying epidemic methicillin resistant Staphylococcus aureus strains | |
| ES2287287T3 (es) | Secuencia del gen rpob de la bacteria tropheryma whippelii y oligonucleotido para el diagnostico molecular de la enfermedad de whipple. | |
| López Meza et al. | Molecular characterization of Staphylococcus spp. isolates associated with bovine mastitis in Tarímbaro, Michoacán, Mexico. | |
| ES2642804T3 (es) | Ensayo para la detección de Chlamydia trachomatis | |
| Feng et al. | Establishment of a multiplex PCR system to diagnose tuberculosis and other bacterial infections |